Cargando…
S100A9 Tetramers, Which are Ligands of CD85j, Increase the Ability of MVA(HIV)-Primed NK Cells to Control HIV Infection
Natural killer (NK) cells are the major antiviral effector population of the innate immune system. We previously found that S100A9 is a novel ligand of the receptor CD85j and that S100A9 tetramers enhance the anti-HIV activity of NK cells. Also, we found that dendritic cells (DCs) infected by the HI...
Autores principales: | Moreno-Nieves, Uriel Y., Didier, Céline, Lévy, Yves, Barré-Sinoussi, Françoise, Scott-Algara, Daniel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4585218/ https://www.ncbi.nlm.nih.gov/pubmed/26441983 http://dx.doi.org/10.3389/fimmu.2015.00478 |
Ejemplares similares
-
S100A9 protein is a novel ligand for the CD85j receptor and its interaction is implicated in the control of HIV-1 replication by NK cells
por: Arnold, Vincent, et al.
Publicado: (2013) -
The CD85j(+) NK Cell Subset Potently Controls HIV-1 Replication in Autologous Dendritic Cells
por: Scott-Algara, Daniel, et al.
Publicado: (2008) -
S100A9 protein is a novel ligand for the receptor CD85j and their interaction is implicated in the NK cell-mediated control of HIV-1 replication
por: Moreno Nieves, UY, et al.
Publicado: (2012) -
HIV/AIDS, more than 25 years later: which challenges remain?
por: Barré-Sinoussi, Françoise
Publicado: (2011) -
OA02-06 LB. Recombinant modified Vaccinia virus ankara expressing HIV-1 genes activates NK subset capable of controlling HIN infection in vitro
por: Cummings, J, et al.
Publicado: (2009)